Results 241 to 250 of about 6,419,415 (265)

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

Aging and Cancer, EarlyView.
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi, Emily Herdman, Danielle Westmark, Vijaya R. Bhatt   +3 more
wiley   +1 more source

RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu, Xin Duan, Fatemeh Peymani, Jia Wang, Chengjia Bao, Chaolong Xu, Ying Zou, Zixuan Zhang, Yunxi Zhang, Tongyue Li, Martin Pavlov, Junling Wang, Minhan Song, Tianyu Song, Xiaodi Han, Mingxi Sun, Danmin Shen, Ruoyu Duan, Huafang Jiang, Manting Xu, Holger Prokisch, Fang Fang   +21 more
wiley   +1 more source

New Findings Regarding the Effects of Selected Blue Food Colorants (Genipin, Patent Blue V, and Brilliant Blue FCF) on the Hemostatic Properties of Blood Components In Vitro. [PDF]

Nutrients
Olas B, Kontek B, Sławińska N, Białecki J.   +3 more
europepmc   +1 more source

Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons, Nuria Guillen, Jordi Sarto, Neus Falgàs, Sergi Borrego‐Écija, Diana Esteller‐Gauxax, Magda Castellví, Adrià Tort‐Merino, Agnès Pérez‐Millan, Anna Antonell, Josep M. Augè Fradera, Gerard Piñol, Iolanda Riba, Anna Carnes‐Vendrell, Marta Cullell, Maria Teresa Osuna, Lorena Bajo, Teresa Romero, Eva Bonjoch, Joan Bello, Susana Fernández, Marta Balagué, Isabel Gómez‐Ruiz, Anuncia Boltes, Claustre Pont, Raquel Cuevas, Sara Carrillo, Laura Iglesias, Teresa Maria Casadevall Codina, Lorena Grau Guinea, Fernando Jose Espada, Raquel Sánchez‐Valle, Mircea Balasa, Albert Lladó   +33 more
wiley   +1 more source

Audit-based corrective and preventive actions to reduce wastage of blood components at a single blood center: A quality improvement study. [PDF]

Asian J Transfus Sci
Gnanaraj J, Kulkarni R, Sahoo D, Basavarajegowda A.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MCED Blood Test Boosts Cancer Detection in Symptomatic Patients

Ca-A Cancer Journal for Clinicians, 2023
Mike Fillon
exaly  

Blood Component Therapy for Cancer

Ca-A Cancer Journal for Clinicians, 1977
Benjamin Lichtiger, B Lichtiger
exaly  

How to Perform the Fecal Occult Blood Test

Ca-A Cancer Journal for Clinicians, 1984
Finlay Macrae, Martin Fleisher, F A Macrae   +2 more
exaly  

Blood and Lymph Vessel Tumors

Ca-A Cancer Journal for Clinicians, 1972
Richard D Brasfield, T K Das Gupta, Tapas K Das Gupta   +2 more
exaly  

Fecal Occult Blood Test

Ca-A Cancer Journal for Clinicians, 1986
Roscoe E Miller, Stanley M Chernish, Dean D. T. Maglinte   +2 more
exaly